Press release MHRA approves GLP –one receptor agonist semaglutide to lessen risk of great coronary heart issues in obese or overweight Grown ups Semaglutide is the main weight reduction drug permitted in britain like a preventative treatment method for those with established heart problemsTake in well, live improved, stay wholesome - Enroll in ou